Glaukos (GKOS) Stock Price
$125.9 20%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Glaukos, AI stock picks, stock alerts and much more.
GKOS AI Stock Analysis
AI stock analysis for GKOS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Glaukos (GKOS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Glaukos (GKOS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Glaukos (GKOS), currently trading at $125.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GKOS
-
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
-
Symbol
GKOS
-
Market
NYSE
-
Industry
Medical - Devices
-
Market Cap
6.9B
Similar Stocks
 |
Abbott Laboratories ABT |
$134.9 1.3% |
7 |
 |
Boston Scientific BSX |
$104.5 0.8% |
7 |
 |
Edwards Lifesciences EW |
$73.3 1.9% |
6 |
 |
Medtronic MDT |
$89.94 2.3% |
7 |
 |
Stryker SYK |
$382.8 0.9% |
7 |
News
GKOS Alternative Data
Web Traffic
Glaukos receives an estimated 20401 monthly visitors to glaukos.com.
-
Web Traffic
20401
-
Change from Previous Month
1.3%
-
3 Month Change
13%
-
YoY Change
13%
Reddit Mentions
Glaukos has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
News Mentions
Glaukos was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
0%
Twitter Followers
Glaukos has 1,633 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
1633
-
Daily Change
0.1%
-
1 Month Change
0.2%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Glaukos has engaged 150 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
150
-
Daily Change
7.4%
-
1 Month Change
26.1%
-
3 Month Change
29.2%
-
YoY Change
29.2%
LinkedIn Followers
27,915 are following Glaukos on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
27915
-
Daily Change
0.1%
-
1 Month Change
1.8%
-
3 Month Change
4.6%
Job Postings
Glaukos has an estimated 23 open job postings, which is down -8% over the last month.
-
Job Postings
23
-
Daily Change
0%
-
1 Month Change
8%
-
3 Month Change
20.7%
-
YoY Change
20.7%
LinkedIn Employees
According to LinkedIn, Glaukos has 894 employees, up by 1% over the last month.
-
LinkedIn Employees
894
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.1%
-
YoY Change
2.1%
Instagram Followers
Glaukos has 3,169 Instagram Followers on its main Instagram account, up by 1.3% over the last month.
-
Instagram Followers
3169
-
Daily Change
0.1%
-
1 Month Change
1.3%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Business Outlook
-
Business Outlook
85
-
Change from Previous Month
4.5%
-
3 Month Change
0%
-
YoY Change
0%
GKOS Financials
GKOS Key Metrics
-
Total Revenue
$96.7M
-
Net Income
-$21.4M
-
Earnings per Share
-$0.39
-
Free cash flow
-$11M
-
EBITDA
-$24.7M
-
EBITDA Ratio
-0.255095
-
Total Assets
$926.5M
GKOS 2-year Revenue & Income
GKOS 2-year Free Cash Flow
GKOS Technicals
GKOS SMA
GKOS RSI
FAQ
What's the current price of Glaukos (GKOS) Stock?
The price of an Glaukos (GKOS) share is $125.9.
What's the market cap of Glaukos?
The current market cap of Glaukos is 6.9B.
Should I buy or sell GKOS?
Glaukos shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Glaukos is better viewed as a hold or accumulate position while waiting for further developments.
Is Glaukos a good investment?
The current analysis of Glaukos' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Glaukos' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Glaukos (GKOS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Glaukos stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Glaukos (GKOS) that investors often compare it to?
Glaukos (GKOS) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.
What is the forecast for Glaukos' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Glaukos' stock price to be around $129.7 in 2026. Starting from the current price of $125.9, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy Glaukos (GKOS) Stock?
Glaukos stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Glaukos shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.